ArticleTherapeutic advances in drug safety2022
Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data.
Chengcheng Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.